Wilmington Savings Fund Society’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $578K | Sell |
6,387
-37
| -0.6% | -$3.1K | 0.01% | 395 |
|
|
2026
Q1 | $514K | Hold |
6,424
| – | – | 0.01% | 413 |
|
|
2025
Q4 | $548K | Sell |
6,424
-1,032
| -14% | -$84.7K | 0.01% | 406 |
|
|
2025
Q3 | $580K | Sell |
7,456
-2,198
| -23% | -$172K | 0.01% | 383 |
|
|
2025
Q2 | $755K | Buy |
9,654
+1,404
| +17% | +$105K | 0.01% | 487 |
|
|
2025
Q1 | $598K | Buy |
8,250
+30
| +0.4% | +$2.15K | 0.01% | 535 |
|
|
2024
Q4 | $609K | Sell |
8,220
-886
| -10% | -$62K | 0.01% | 533 |
|
|
2024
Q3 | $601K | Buy |
9,106
+5,420
| +147% | +$394K | 0.01% | 530 |
|
|
2024
Q2 | $340K | Buy |
3,686
+327
| +10% | +$29K | 0.01% | 296 |
|
|
2024
Q1 | $321K | Buy |
+3,359
| New | +$282K | 0.01% | 304 |
|
|
2023
Q3 | $257K | Buy |
3,714
+129
| +4% | +$10.4K | 0.01% | 315 |
|
|
2023
Q2 | $338K | Hold |
3,585
| – | – | 0.01% | 302 |
|
|
2023
Q1 | $296K | Sell |
3,585
-53
| -1% | -$4.17K | 0.01% | 299 |
|
|
2022
Q4 | $272K | Hold |
3,638
| – | – | 0.01% | 307 |
|
|
2022
Q3 | $300K | Buy |
3,638
+53
| +1% | +$5.1K | 0.01% | 302 |
|
|
2022
Q2 | $341K | Sell |
3,585
-13
| -0.4% | -$1.35K | 0.02% | 294 |
|
|
2022
Q1 | $424K | Sell |
3,598
-2,053
| -36% | -$230K | 0.02% | 283 |
|
|
2021
Q4 | $732K | Sell |
5,651
-2,158
| -28% | -$252K | 0.03% | 257 |
|
|
2021
Q3 | $884K | Sell |
7,809
-412
| -5% | -$47K | 0.03% | 239 |
|
|
2021
Q2 | $852K | Sell |
8,221
-50
| -0.6% | -$4.71K | 0.03% | 242 |
|
|
2021
Q1 | $692K | Sell |
8,271
-80
| -1% | -$6.76K | 0.03% | 250 |
|
|
2020
Q4 | $761K | Sell |
8,351
-40
| -0.5% | -$3.32K | 0.03% | 241 |
|
|
2020
Q3 | $670K | Buy |
8,391
+1,188
| +16% | +$92.7K | 0.03% | 241 |
|
|
2020
Q2 | $497K | Sell |
7,203
-483
| -6% | -$34.3K | 0.02% | 259 |
|
|
2020
Q1 | $483K | Sell |
7,686
-1,068
| -12% | -$77K | 0.03% | 246 |
|
|
2019
Q4 | $680K | Buy |
8,754
+114
| +1% | +$8.9K | 0.03% | 223 |
|
|
2019
Q3 | $634K | Sell |
8,640
-375
| -4% | -$26.3K | 0.03% | 219 |
|
|
2019
Q2 | $555K | Buy |
9,015
+1,275
| +16% | +$77.1K | 0.03% | 243 |
|
|
2019
Q1 | $494K | Buy |
7,740
+6
| +0.1% | +$342 | 0.03% | 253 |
|
|
2018
Q4 | $395K | Hold |
7,734
| – | – | 0.02% | 266 |
|
|
2018
Q3 | $449K | Sell |
7,734
-60
| -0.8% | -$2.94K | 0.02% | 264 |
|
|
2018
Q2 | $378K | Buy |
7,794
+276
| +4% | +$12.9K | 0.02% | 279 |
|
|
2018
Q1 | $350K | Sell |
7,518
-420
| -5% | -$18.2K | 0.02% | 273 |
|
|
2017
Q4 | $298K | Buy |
+7,938
| New | +$291K | 0.02% | 292 |
|
Other funds holding EW
Wilmington Savings Fund Society's EW Position: Q2 2026 in Review
Wilmington Savings Fund Society reduced its Edwards Lifesciences (EW) stake by 0.58% in Q2 2026, selling an estimated $3.1K and leaving 6,387 shares worth $578K. The position accounts for 0.01% of the portfolio, ranked #395.
Wilmington Savings Fund Society first reported a position in EW in Q4 2017 and has held it in 34 quarters since. The position peaked at $884K in Q3 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Wilmington Savings Fund Society held 6,387 shares of Edwards Lifesciences worth $578K as of Q2 2026.
- Wilmington Savings Fund Society sold 37 Edwards Lifesciences shares in Q2 2026, an estimated $3.1K.
- Edwards Lifesciences made up 0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #395 holding.
- Wilmington Savings Fund Society first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 34 quarters since.
- Wilmington Savings Fund Society's Edwards Lifesciences position peaked at $884K in Q3 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.